Report Detail

Other Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Insights and Forecast to 2027

  • RnM3650504
  • |
  • 11 June, 2021
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Other

Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.

A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
The classification of Pacemakers and Cardiac Resynchronization Therapy Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2018 is about 47.8%. The ICD in 2018 is about 38.3%.Pacemakers and Cardiac Resynchronization Therapy Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2018 is 43%. And the market share used bradycardia in 2018 is 39%. North America is the largest consumption place, with a consumption market share nearly 48% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 26.2%, Pacemakers and Cardiac Resynchronization Therapy Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

Market Analysis and Insights: Global Pacemakers and Cardiac Resynchronization Therapy Devices Market
The global Pacemakers and Cardiac Resynchronization Therapy Devices market is valued at US$ 10650 million in 2019. The market size will reach US$ 13220 million by the end of 2026, growing at a CAGR of 3.1% during 2021-2026.

Global Pacemakers and Cardiac Resynchronization Therapy Devices Scope and Market Size
Pacemakers and Cardiac Resynchronization Therapy Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pacemakers and Cardiac Resynchronization Therapy Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Pacemaker
ICD
CRT
In 2018, Pacemaker accounted for a major share of 47% in the global Pacemakers and Cardiac Resynchronization Therapy Devices market. And this product segment is poised to reach 736 K Units by 2025 from 670 K Units in 2019.

Segment by Application
Bradycardia
Tachycardia
Heart Failure
Others

By Company
Medtronic
St. Jude Medical (Abbott)
Boston Scientific
Biotronik
MicroPort
Medico
Lepu (Qinming Medical)
IMZ
Cardioelectronica
Pacetronix

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia


1 Study Coverage

  • 1.1 Pacemakers and Cardiac Resynchronization Therapy Devices Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size Growth Rate by Type
    • 1.4.2 Pacemaker
    • 1.4.3 ICD
    • 1.2.4 CRT
  • 1.3 Market by Application
    • 1.3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Size Growth Rate by Application
    • 1.3.2 Bradycardia
    • 1.3.3 Tachycardia
    • 1.3.4 Heart Failure
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Sales
    • 2.4.1 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Sales (2016-2021)
    • 2.4.2 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Sales (2022-2027)
  • 2.5 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Revenue
    • 2.5.1 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Manufacturers
    • 3.1.1 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Pacemakers and Cardiac Resynchronization Therapy Devices Sales in 2020
  • 3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Manufacturers
    • 3.2.1 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Pacemakers and Cardiac Resynchronization Therapy Devices Revenue in 2020
  • 3.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type
    • 4.1.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Historical Sales by Type (2016-2021)
    • 4.1.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Type (2016-2027)
  • 4.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type
    • 4.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Type (2016-2027)
  • 4.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Type
    • 4.3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Type (2016-2021)
    • 4.3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application
    • 5.1.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Historical Sales by Application (2016-2021)
    • 5.1.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Sales Market Share by Application (2016-2027)
  • 5.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application
    • 5.2.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Revenue Market Share by Application (2016-2027)
  • 5.3 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Application
    • 5.3.1 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price by Application (2016-2021)
    • 5.3.2 Global Pacemakers and Cardiac Resynchronization Therapy Devices Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Type
    • 6.1.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2016-2027)
    • 6.1.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2016-2027)
  • 6.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Application
    • 6.2.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2016-2027)
    • 6.2.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2016-2027)
  • 6.3 North America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 6.3.1 North America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2016-2027)
    • 6.3.2 North America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Type
    • 7.1.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2017-2027)
    • 7.1.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2017-2027)
  • 7.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Application
    • 7.2.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2017-2027)
    • 7.2.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2017-2027)
  • 7.3 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 7.3.1 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2017-2027)
    • 7.3.2 Europe Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Type
    • 8.1.1 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Application
    • 8.2.1 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Region
    • 8.3.1 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Type
    • 9.1.1 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2019-2027)
    • 9.1.2 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2019-2027)
  • 9.2 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Application
    • 9.2.1 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2019-2027)
    • 9.2.2 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2019-2027)
  • 9.3 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 9.3.1 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2019-2027)
    • 9.3.2 Latin America Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Type
    • 6.1.1 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Application
    • 6.2.1 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Market Size by Country
    • 6.3.1 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Pacemakers and Cardiac Resynchronization Therapy Devices Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Overview
    • 11.1.3 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.1.5 Medtronic Related Developments
  • 11.2 St. Jude Medical (Abbott)
    • 11.2.1 St. Jude Medical (Abbott) Corporation Information
    • 11.2.2 St. Jude Medical (Abbott) Overview
    • 11.2.3 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 St. Jude Medical (Abbott) Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.2.5 St. Jude Medical (Abbott) Related Developments
  • 11.3 Boston Scientific
    • 11.3.1 Boston Scientific Corporation Information
    • 11.3.2 Boston Scientific Overview
    • 11.3.3 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Boston Scientific Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.3.5 Boston Scientific Related Developments
  • 11.4 Biotronik
    • 11.4.1 Biotronik Corporation Information
    • 11.4.2 Biotronik Overview
    • 11.4.3 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Biotronik Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.4.5 Biotronik Related Developments
  • 11.5 MicroPort
    • 11.5.1 MicroPort Corporation Information
    • 11.5.2 MicroPort Overview
    • 11.5.3 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 MicroPort Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.5.5 MicroPort Related Developments
  • 11.6 Medico
    • 11.6.1 Medico Corporation Information
    • 11.6.2 Medico Overview
    • 11.6.3 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Medico Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.6.5 Medico Related Developments
  • 11.7 Lepu (Qinming Medical)
    • 11.7.1 Lepu (Qinming Medical) Corporation Information
    • 11.7.2 Lepu (Qinming Medical) Overview
    • 11.7.3 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Lepu (Qinming Medical) Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.7.5 Lepu (Qinming Medical) Related Developments
  • 11.8 IMZ
    • 11.8.1 IMZ Corporation Information
    • 11.8.2 IMZ Overview
    • 11.8.3 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 IMZ Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.8.5 IMZ Related Developments
  • 11.9 Cardioelectronica
    • 11.9.1 Cardioelectronica Corporation Information
    • 11.9.2 Cardioelectronica Overview
    • 11.9.3 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Cardioelectronica Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.9.5 Cardioelectronica Related Developments
  • 11.10 Pacetronix
    • 11.10.1 Pacetronix Corporation Information
    • 11.10.2 Pacetronix Overview
    • 11.10.3 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Pacetronix Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.10.5 Pacetronix Related Developments
  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Overview
    • 11.1.3 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Medtronic Pacemakers and Cardiac Resynchronization Therapy Devices Product Description
    • 11.1.5 Medtronic Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Pacemakers and Cardiac Resynchronization Therapy Devices Value Chain Analysis
  • 12.2 Pacemakers and Cardiac Resynchronization Therapy Devices Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Pacemakers and Cardiac Resynchronization Therapy Devices Production Mode & Process
  • 12.4 Pacemakers and Cardiac Resynchronization Therapy Devices Sales and Marketing
    • 12.4.1 Pacemakers and Cardiac Resynchronization Therapy Devices Sales Channels
    • 12.4.2 Pacemakers and Cardiac Resynchronization Therapy Devices Distributors
  • 12.5 Pacemakers and Cardiac Resynchronization Therapy Devices Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Pacemakers and Cardiac Resynchronization Therapy Devices Industry Trends
  • 13.2 Pacemakers and Cardiac Resynchronization Therapy Devices Market Drivers
  • 13.3 Pacemakers and Cardiac Resynchronization Therapy Devices Market Challenges
  • 13.4 Pacemakers and Cardiac Resynchronization Therapy Devices Market Restraints

14 Key Findings in The Global Pacemakers and Cardiac Resynchronization Therapy Devices Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Summary:
    Get latest Market Research Reports on Pacemakers and Cardiac Resynchronization Therapy Devices. Industry analysis & Market Report on Pacemakers and Cardiac Resynchronization Therapy Devices is a syndicated market report, published as Global Pacemakers and Cardiac Resynchronization Therapy Devices Market Insights and Forecast to 2027. It is complete Research Study and Industry Analysis of Pacemakers and Cardiac Resynchronization Therapy Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,861.20
    5,791.80
    7,722.40
    4,508.00
    6,762.00
    9,016.00
    763,371.00
    1,145,056.50
    1,526,742.00
    408,464.00
    612,696.00
    816,928.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report